je.st
news
Alexion buys Lexington rare drug maker Synageva for $8.4B
2015-06-23 15:40:55| Biotech - Topix.net
With the completion of the $8.4 billion acquisition of Synageva BioPharma by a Connecticut pharmaceutical company specializing in marketing extremely rare drugs, the Bay State has one fewer locally-owned, publicly-traded biotech firm. In a statement today, Alexion , which reported 2,273 employees as of the end of last year, said its combination with 282-employee Synageva gives it a new total head count of "more than 2,800 employees."
Tags: drug
rare
maker
buys
Category:Biotechnology and Pharmaceuticals